Skip to content

Clinical Study on Pain Phenotype and Efficacy of Traditional Chinese Medicine Press Needle Intervention in Children with Juvenile Idiopathic Arthritis

Clinical Study on Pain Phenotype Analysis and Therapeutic Efficacy of Traditional Chinese Medicine Press Needle Intervention in Children with Juvenile Idiopathic Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002247
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-18
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Juvenile Idiopathic Arthritis

Interventions

Press Needle Group:Basic treatment + routine nursing + press - needle therapy
Non-Press Needle Group:Basic treatment + routine nursing + no press-needle therapy

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) Age range: 3-18 years; (2) Diagnosed with JIA according to ILAR classification criteria; (3) =1 month since initial diagnosis; (4) Wong-Baker pain score =4 at enrollment; (5) Classifiable pain phenotype identified by our research team's assessment tool; (6) Informed consent from patients and legal guardians; (7) Good compliance to complete the study; (8) Patients already receiving standardized conventional drug therapy with confirmed regimen at enrollment.

Exclusion criteria

Exclusion criteria: (1) Severe organic diseases (e.g., congenital heart disease, kidney diseases); (2) sJIA with macrophage activation syndrome; (3) Comorbid rheumatic/immune diseases (e.g., SLE, dermatomyositis); (4) Active infections or malignancies; (5) Infection/ulceration at acupuncture sites; (6) Metal implants or severe deformities at press needle sites; (7) Allergy to press needle materials; (8) Recent (within 4 weeks) acupuncture/TCM treatments including herbal medicine.

Design outcomes

Primary

MeasureTime frame
Wong-Baker FACES Pain Rating Scale;

Secondary

MeasureTime frame
Joint Mobility & Daily Activity Score;C-reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR);Patient and Parent Satisfaction;Adverse Event Incidence Rate;

Countries

China

Contacts

Public ContactWei Xiaoqiong

Children's Hospital Affiliated to Chongqing Medical University

519875405@qq.com13752812269

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026